• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诊断困境:无黑色素 BRAF 阴性转移性恶性黑色素瘤表现较晚,类似于透明细胞肉瘤:病例报告。

Diagnostic dilemma: late presentation of amelanotic BRAF-negative metastatic malignant melanoma resembling clear cell sarcoma: a case report.

机构信息

University of Wisconsin School of Medicine and Public Health, 750 Highland Ave, Madison, WI, USA.

出版信息

Diagn Pathol. 2013 Nov 25;8:192. doi: 10.1186/1746-1596-8-192.

DOI:10.1186/1746-1596-8-192
PMID:24274261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4222667/
Abstract

UNLABELLED

Clear cell sarcoma is a rare cancer primarily of tendons, fascia, and aponeuroses that can be difficult to discern from primary cutaneous malignant melanoma. The two cancers share several histological markers, with most cases of both cancers staining positively for S-100, HMB-45, and melanin. Primary therapy of both cancers involves wide local excision, but while systemic therapy has proven benefit for malignant melanoma, it has not been established for clear cell sarcoma.We report the case of a 58 year old woman with a large, ulcerated, fungating mass on her left lower leg. Frozen section of the mass showed a malignant epithelioid and spindle cell tumor confined to the subcutaneous tissue. A provisional diagnosis of soft-tissue sarcoma was made. Through in-depth study of initial biopsy with immunohistochemistry for S-100, HMB-45, MART-1, and MITF, along with karyotyping and FISH analysis for EWS gene rearrangement, the diagnosis of amelanotic malignant melanoma was confirmed. The patient then underwent systemic treatment with ipilimumab upon recurrence with good response.

VIRTUAL SLIDES

The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1989338475107348.

摘要

未注明

透明细胞肉瘤是一种罕见的癌症,主要发生于肌腱、筋膜和腱膜,很难与原发性皮肤恶性黑色素瘤区分。这两种癌症有几个组织学标志物,大多数透明细胞肉瘤和恶性黑色素瘤的病例均对 S-100、HMB-45 和黑色素呈阳性染色。两种癌症的主要治疗方法均为广泛局部切除,但恶性黑色素瘤的全身治疗已被证明有效,而透明细胞肉瘤的全身治疗尚未确定。我们报告了一例 58 岁女性,左小腿有一个大的溃疡性、隆起性肿块。肿块的冷冻切片显示恶性上皮样和梭形细胞肿瘤局限于皮下组织。初步诊断为软组织肉瘤。通过对初始活检进行深入研究,包括 S-100、HMB-45、MART-1 和 MITF 的免疫组织化学染色,以及 EWS 基因重排的核型分析和 FISH 分析,最终确诊为无黑色素恶性黑色素瘤。随后,患者在复发时接受了伊匹单抗的全身治疗,反应良好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ee/4222667/faf6a3b07c53/1746-1596-8-192-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ee/4222667/faf6a3b07c53/1746-1596-8-192-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ee/4222667/faf6a3b07c53/1746-1596-8-192-1.jpg

相似文献

1
Diagnostic dilemma: late presentation of amelanotic BRAF-negative metastatic malignant melanoma resembling clear cell sarcoma: a case report.诊断困境:无黑色素 BRAF 阴性转移性恶性黑色素瘤表现较晚,类似于透明细胞肉瘤:病例报告。
Diagn Pathol. 2013 Nov 25;8:192. doi: 10.1186/1746-1596-8-192.
2
A case report of cutaneous melanocytoma with CRTC1-TRIM11 fusion: Is CMCT distinct from clear cell sarcoma of soft tissue?黑素细胞瘤伴 CRTC1-TRIM11 融合的病例报告:CMCT 是否不同于软组织透明细胞肉瘤?
Pathol Int. 2019 Aug;69(8):496-501. doi: 10.1111/pin.12826. Epub 2019 Jul 5.
3
Cutaneous clear cell sarcoma: report of three cases of a potentially underestimated mimicker of spindle cell melanoma.皮肤透明细胞肉瘤:三例可能被低估的梭形细胞黑色素瘤模仿者的报告。
Am J Dermatopathol. 2012 Aug;34(6):619-25. doi: 10.1097/DAD.0b013e3182473190.
4
Identification of biomarkers to distinguish clear cell sarcoma from malignant melanoma.鉴定生物标志物以区分透明细胞肉瘤与恶性黑色素瘤。
Hum Pathol. 2012 Sep;43(9):1463-70. doi: 10.1016/j.humpath.2011.10.022. Epub 2012 Mar 9.
5
Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma.用于EWS基因重排的双色、分离式荧光原位杂交可将软组织透明细胞肉瘤与恶性黑色素瘤区分开来。
Mod Pathol. 2005 Dec;18(12):1585-90. doi: 10.1038/modpathol.3800503.
6
Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma.皮肤透明细胞肉瘤:12 例临床病理、免疫组化和分子分析,强调其与皮肤黑色素瘤的区别。
Am J Surg Pathol. 2010 Feb;34(2):216-22. doi: 10.1097/PAS.0b013e3181c7d8b2.
7
Clear cell melanoma: a cutaneous clear cell malignancy.透明细胞黑色素瘤:一种皮肤透明细胞恶性肿瘤。
Arch Pathol Lab Med. 2014 Oct;138(10):1328-36. doi: 10.5858/arpa.2014-0307-CC.
8
Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts).恶性黑色素瘤在基因上与肌腱和腱膜透明细胞肉瘤(软组织恶性黑色素瘤)不同。
Br J Cancer. 2001 Feb;84(4):535-8. doi: 10.1054/bjoc.2000.1628.
9
A rare case of primary clear cell sarcoma of the pubic bone resembling small round cell tumor: an unusual morphological variant.罕见的原发性耻骨透明细胞肉瘤类似于小圆细胞肿瘤:一种不常见的形态学变异型。
BMC Cancer. 2012 Nov 21;12:538. doi: 10.1186/1471-2407-12-538.
10
MUM-1 expression differentiates tumors in the PEComa family from clear cell sarcoma and melanoma.MUM-1表达可将PEComa家族肿瘤与透明细胞肉瘤和黑色素瘤区分开来。
Int J Surg Pathol. 2012 Feb;20(1):29-36. doi: 10.1177/1066896911418204. Epub 2011 Sep 8.

引用本文的文献

1
Primary pulmonary clear cell sarcoma-the first two reported cases.原发性肺透明细胞肉瘤——首例报告的两例病例
Virchows Arch. 2016 Jul;469(1):111-7. doi: 10.1007/s00428-016-1943-8. Epub 2016 Apr 25.
2
Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers.基因组重排在乳腺癌中的新作用:借鉴其他癌症的知识
Biomark Cancer. 2016 Feb 11;8(Supple 1):1-14. doi: 10.4137/BIC.S34417. eCollection 2016.
3
Research on tumorigenicity of cinnamaldehyde in melanoma cell lines and its mechanism.肉桂醛在黑色素瘤细胞系中的致瘤性及其机制研究。

本文引用的文献

1
Lack of SF3B1 R625 mutations in cutaneous melanoma.皮肤黑色素瘤中缺乏 SF3B1 R625 突变。
Diagn Pathol. 2013 May 21;8:87. doi: 10.1186/1746-1596-8-87.
2
High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.高 MCM3 表达是不良预后的独立生物标志物,与前瞻性恶性黑色素瘤队列中 RBM3 表达降低相关。
Diagn Pathol. 2012 Jul 17;7:82. doi: 10.1186/1746-1596-7-82.
3
Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma.
Tumour Biol. 2014 Jun;35(6):5717-22. doi: 10.1007/s13277-014-1757-8. Epub 2014 Mar 19.
黑色素瘤 III 期多中心选择性淋巴结清扫试验(MSLT-I 和 MSLT-II)的概述和更新。
Clin Exp Metastasis. 2012 Oct;29(7):699-706. doi: 10.1007/s10585-012-9503-3. Epub 2012 Jun 24.
4
Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases.软组织透明细胞肉瘤(恶性黑色素瘤):52例临床病理研究
Dermatol Res Pract. 2012;2012:984096. doi: 10.1155/2012/984096. Epub 2012 May 30.
5
Current management and novel agents for malignant melanoma.恶性黑素瘤的当前治疗方法和新型药物。
J Hematol Oncol. 2012 Feb 14;5:3. doi: 10.1186/1756-8722-5-3.
6
FISH as an effective diagnostic tool for the management of challenging melanocytic lesions.荧光原位杂交(FISH)作为一种有效的诊断工具,用于处理具有挑战性的黑素细胞性病变。
Diagn Pathol. 2011 Aug 11;6:76. doi: 10.1186/1746-1596-6-76.
7
Final version of 2009 AJCC melanoma staging and classification.2009 年 AJCC 黑色素瘤分期与分类的最终版。
J Clin Oncol. 2009 Dec 20;27(36):6199-206. doi: 10.1200/JCO.2009.23.4799. Epub 2009 Nov 16.
8
Clear cell sarcoma of tendons and aponeuroses: a review.肌腱和腱膜透明细胞肉瘤:综述
Arch Pathol Lab Med. 2007 Jan;131(1):152-6. doi: 10.5858/2007-131-152-CCSOTA.
9
Clear cell sarcoma of soft tissues.软组织透明细胞肉瘤
J Surg Oncol. 2007 May 1;95(6):519-22. doi: 10.1002/jso.20730.
10
Melanoma.黑色素瘤
N Engl J Med. 2006 Jul 6;355(1):51-65. doi: 10.1056/NEJMra052166.